<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100682</url>
  </required_header>
  <id_info>
    <org_study_id>HPVaxResponse Study</org_study_id>
    <nct_id>NCT03100682</nct_id>
  </id_info>
  <brief_title>Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease</brief_title>
  <official_title>Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease: a Prospective, Observational Multi-centre Vaccine Surveillance Study (HPVaxResponse Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Due to their immunosuppressive therapy, solid-organ transplant (SOT) recipients bear a 10 to
      100 times higher risk of human papillomavirus (HPV)-associated malignancies than healthy
      individuals. The objectives of this observational, non-interventional multi-national,
      multi-centre research project are to gain an insight into current HPV vaccination strategies
      and to investigate the immune response to different routinely administered HPV vaccines in
      European paediatric SOT candidates and immunocompromised transplant recipients, enabling
      patients at risk of vaccination failure to be identified.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 18, 2017</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Immune Response to HPV vaccine</measure>
    <time_frame>Change of immune response from baseline (prior to vaccination) to 4-12 weeks after vaccination and to 18+- 3 months after vaccination will be assessed.</time_frame>
    <description>HPV vaccine antibodies</description>
  </primary_outcome>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Paediatric Kidney or Liver Transplantation</condition>
  <condition>Chronic Kidney Disease</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum rest material
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Paediatric Kidney and/or Liver transplant recipients Paediatric patients with CKD
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Paediatric Kidney and/or Liver transplant recipients

          -  Paediatric patients with CKD

          -  Who receive HPV vaccination according to country-specific vaccine schedule

        Exclusion Criteria:

          -  No HPV vaccination according to country-specific vaccine schedule

          -  No written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Britta Hoecker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital of Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Britta Hoecker, MD</last_name>
    <phone>+49 6221 564002</phone>
    <email>britta.hoecker@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Britta Hoecker, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>PD Dr. med. Britta Hoecker</investigator_full_name>
    <investigator_title>Privatdozentin Dr. med. Britta Hoecker</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

